Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency (CONFIRM-HF)
This study is currently recruiting participants.
Verified December 2012
by Vifor Inc.
Study NCT01453608 Information provided by Vifor Inc.
First Received on October 13, 2011. Last Updated on December 19, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Heart Failure
Additional conditions recognized in this trial
More general conditions related to this trial
Iron Metabolism Disorders
Interventions listed in this trial
Ferinject (ferric carboxymaltose)
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
ICON Clinical Research
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers